New developments in the fight to save little Charlie Gard’s life.
A U.S. doctor will travel to the U.K. to examine the 11-month-old who’s suffering from a rare genetic disorder.
Michio Hirano of Columbia University Medical Center in New York, specializes in mitochondrial diseases and genetic myopathies.
He says he’s treated others who have suffered from conditions similar to Gard’s in which the body’s mitochondria stop working, causing muscle weakness and brain damage.
Gard’s parents have been locked in a high-profile battle with the hospital over whether using an experimental treatment is in their son’s best interest.
Both President Trump, Pope Francis, and his parents have called on the child to receive the experimental treatment.
But the hospital has petitioned the court to remove his ventilator so he can “die with dignity” rather than using a treatment they think will cause him pain.
The American doctor testified saying, little Charlie will have a 10% chance of improving with the experimental treatment available in the U.S.
High Court Judge Nicholas Francis has promised to postpone the ruling until July 25th, saying he’s “open-minded about the evidence” that will come from the doctor’s visit.